Morten Lock Hansen

Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation

Morten Lock Hansen, Rikke Sørensen, Mette T. Clausen et al. · Archives of Internal Medicine · 2010 · 846 citations

Medicine, Cardiology, Pharmacotherapy +17

Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data

Rikke Sørensen, Morten Lock Hansen, Steen Z. Abildstrøm et al. · The Lancet · 2009 · 572 citations

Medicine, Cardiology, Pharmacology +12

Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk

Tina Ken Schramm, Gunnar Gislason, Lars Køber et al. · Circulation · 2008 · 541 citations

Medicine, Cardiology, Internal Medicine +12

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study

Jonas Bjerring Olesen, Christian Torp‐Pedersen, Morten Lock Hansen et al. · Thrombosis and Haemostasis · 2012 · 493 citations

Medicine, Cardiology, Clinical Pharmacology +16

Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study

Gregory Y.H. Lip, Jesper Lindhardsen, Deirdre A. Lane et al. · Thrombosis and Haemostasis · 2011 · 428 citations

Medicine, Cardiology, Pharmacotherapy +17